Analyst consensus rating
Vir Biotechnology Analyst Rating: Strong Buy
Direct answer
Vir Biotechnology's consensus rating is Strong Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $21.00.
Forecast evidence checked October 19, 2026.
Get free Vir Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.96
- Average price target
- $21.00
- High price target
- $30.00
- Low price target
- $15.00
- Low target gap
- +50.6%
- Target upside
- +110.8%
- High target gap
- +201.2%
- Target range width
- 150.6%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Vir Biotechnology?
Vir Biotechnology has a verified Strong Buy consensus. The same dataset has an average price target of $21.00.
How far are Vir Biotechnology's low and high targets from the recorded price?
The low target implies +50.6%, while the high target implies +201.2%.
How many analysts are included in Vir Biotechnology's consensus?
The verified consensus includes 9 analysts.
How is Vir Biotechnology's target upside or downside calculated?
The average target of $21.00 is divided by the recorded price of $9.96, then one is subtracted to produce +110.8%. This does not guarantee a future return.
When was Vir Biotechnology's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.